Statement Of Cash Flows [Abstract]

ROQUEFORT THERAPEUTICS PLC - Filing #5968009

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for interest expense
44,587 GBP
58 GBP
Adjustments for interest income
GBP
1,469 GBP
Adjustments for decrease (increase) in trade and other receivables
130,412 GBP
55,851 GBP
Adjustments for depreciation expense
5,404 GBP
3,890 GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.